News & Updates
Filter by Specialty:
PCI yields short-term mortality gains in STEMI patients receiving dialysis
Primary percutaneous coronary intervention (pPCI) is as good as conservative management in terms of the benefit for in-hospital mortality among ST-segment elevation myocardial infarction (STEMI) patients receiving maintenance dialysis, a study has found.
PCI yields short-term mortality gains in STEMI patients receiving dialysis
21 Oct 2021
DOACs on par with LMWH at preventing VTE in cancer patients
Cancer patients receiving either low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) show comparable frequency of venous thromboembolism (VTE), reports a recent study.
DOACs on par with LMWH at preventing VTE in cancer patients
19 Oct 2021
Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients
The combination of aspirin and warfarin therapy appears to increase the risk of bleeding, with little benefit in reducing stroke or cardiovascular events compared with warfarin alone in patients with atrial fibrillation (AF), reveals a study.
Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients
18 Oct 2021
Diabetes, hypertension up risk of stroke
Hypertension and diabetes are the major predictors of stroke that must be controlled and treated like other global high-risk populations for stroke prevention, according to a prospective study in India.
Diabetes, hypertension up risk of stroke
16 Oct 2021
Marine n-3 PUFAs do not affect incident PAD risk
Higher intake of marine n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exerts no significant protective effect against incident peripheral artery disease (PAD), a recent study has found.